Circulating inflammatory monocytes

Biomarker1 paper1 finding

Human trial1

Interventions

1

Semaglutide

downin humans1Very low certainty

1 study

Semaglutide decreases circulating inflammatory monocytes in humans.
Human trialin individuals with T2D≤2.0 mg weekly6 months
Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes · European heart journal · 29 Sep 2026

Semaglutide →

Latest

1

European Heart JournalHuman trial29 Sep

Potential bone marrow-driven reduction of circulating inflammatory monocytes by semaglutide in Type 2 diabetes

GLP-1 receptor agonists